SCHEMBL2989098

SCHEMBL2989098

Cc1ccc(-c2ccc(S(=O)(=O)Nc3cccc([N+](=O)[O-])c3)cc2F)o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 5/20 0.49
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.46
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
EDNRA P25101 1/20 0.43
LMNA P02545 1/20 0.43
NPC1 O15118 1/20 0.43
HSPD1 P10809 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN5 P54829 1/20 0.43
HSPE1 P61604 1/20 0.43
TYMS P04818 1/20 0.43
HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2984221 0.84 HTR6 (0.52) GHSRALDH1A1POLBL3MBTL1PKM
SCHEMBL2992451 0.80 POLB (0.58) GHSRALDH1A1POLBL3MBTL1LMNA
SCHEMBL13245993 0.77 KDM4E (0.48) GHSRL3MBTL1PKM
SCHEMBL2987975 0.76 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1POLBCASP3
SCHEMBL2997886 0.76 KDM4E (0.47) GHSRALDH1A1L3MBTL1
SCHEMBL27927882 0.74 POLB (0.63) ALDH1A1KMT2AMEN1POLBLMNA
SCHEMBL2990049 0.74 LMNA (0.47) GHSRALDH1A1KMT2AMEN1LMNA
SCHEMBL15043011 0.72 ALDH1A1 (0.66) ALDH1A1KMT2AMEN1CASP3SENP8
SCHEMBL893934 0.71 CA2 (0.71) ALDH1A1KMT2AMEN1POLBCASP3
SCHEMBL2979801 0.71 ALDH1A1 (0.50) GHSRALDH1A1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GHSR, GHRHR, GIPR GHSR 1/4885ALDH1A1 2521/4885KMT2A 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.